This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kopple, J. D. Search for Related Content PubMed PubMed Citation Articles by Kopple, J. D. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Nutritional Support Social Bookmarking                         What's this?

1995 Jonathan E. Rhoads Lecture. The Nutrition Management of the Patient With Acute Renal Failure

Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, California, UCLA Schools of Medicine and Public Health, Los Angeles, California

The clinical status of patients with acute renal failure (ARF) varies greatly. Some individuals have only mild or moderate ARF or may have only mild perturbations of their metabolic status. Other patients exhibit a severe reduction in renal function with oliguria or anuria. Depending upon their comorbid conditions, ARF patients may be among the most hypercatabolic patients in the hospital. Clinical trials have not clearly shown a beneficial effect of nutrition support on morbidity or mortality in patients with ARF, although limitations in sample size and experimental design and inclusion of patients with widely disparate clinical conditions may have contributed to the difficulty in demonstrating benefits. Several recent therapeutic approaches that have been studied either in experimental animals with ARF or in small numbers of humans with ARF hold promise for improving clinical outcome. Continuous arteriovenous or venovenous hemofiltration with or without dialysis is such a therapy. In comparison to intermittent hemodialysis this former treatment more safely removes large quantities of water and solutes from critically ill patients with unstable hemodynamics and allows them to receive rather large quantities of nutrients, including amino acids. Also promising are studies in experimental animals with ARF which indicate that several growth factors may accelerate the recovery of renal function. In rats with ARF, insulin-like growth factor 1 both enhances recovery of renal function and suppresses their enhanced catabolism. For most patients with ARF requiring nutrition support, evidence suggests that both essential and nonessential amino acids should be employed. However, there appears to be a therapeutic role for small quantities of essential amino acids, without nonessential amino acids, in selected patients. Data support the importance of proactive measures to prevent fluid and electrolyte imbalances in patients with ARF. (Journal of Parenteral and Enteral Nutrition 20:3-12, 1996)

Journal of Parenteral and Enteral Nutrition, Vol. 20, No. 1, 3-12 (1996)
DOI: 10.1177/014860719602000103


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				V. W. Vanek A.S.P.E.N.--Past, Present, and Future JPEN J Parenter Enteral Nutr, September 1, 2008; 32(5): 535 - 562. [Full Text] [PDF]

				M. L. Esson and R. W. Schrier Diagnosis and Treatment of Acute Tubular Necrosis Ann Intern Med, November 5, 2002; 137(9): 744 - 752. [Abstract] [Full Text] [PDF]

				E. FIACCADORI, M. LOMBARDI, S. LEONARDI, C. F. ROTELLI, G. TORTORELLA, and A. BORGHETTI Prevalence and Clinical Outcome Associated with Preexisting Malnutrition in Acute Renal Failure: A Prospective Cohort Study J. Am. Soc. Nephrol., March 1, 1999; 10(3): 581 - 593. [Abstract] [Full Text]